November 14 – November 18, 2026 | Walter E. Washington Convention Center, Washington, D.C. | Booth #419

Taconic at SfN 2026

Name: SfN
Start: 2026-11-14T20:12:00.000Z
End: 2026-11-18T20:12:00.000Z
Location: Walter E. Washington Convention Center

Taconic offers a diverse portfolio of rodent models and services to support translational neuroscience research across major disease areas. Discover our selection of SfN 2026 posters and neuroscience resources below.

Advance Neuroscience Research with Taconic at SfN 2026

Join Taconic Biosciences at Neuroscience 2026 (SfN) in Washington, D.C., November 14–18, to explore advanced mouse and rat models supporting neurodegenerative disease research, blood-brain barrier (BBB) transport, and CNS drug discovery.

From Alzheimer's and Parkinson's disease models to humanized BBB transport platforms, Taconic provides translational research tools to help researchers investigate disease mechanisms, evaluate therapeutic candidates, and advance CNS drug development.

Meet with our team to learn how Taconic's neurobiology portfolio can support your research. Fill out the calendar to the right to schedule a meeting with us at SfN 2026.

View:

Select One

Overview
Scientific Posters
Meet the Team
Resources

Taconic’s Neuroscience Model Portfolio

Explore Taconic's specialized mouse and rat models designed to support neuroscience research, disease modeling, and therapeutic development.

Model Portfolio

Alzheimer's Disease Models

Taconic offers genetically engineered models for familial and sporadic Alzheimer's disease, including APP/PS1 (ARTE10) and humanized APOE models, to support research into amyloid pathology, neuroinflammation, and disease progression.

View Alzheimer's Disease Mouse Models

Blood–Brain Barrier Transport Platform

Taconic's humanized transferrin receptor 1 (hTFRC) mouse models enable researchers to evaluate receptor-mediated transport across the blood-brain barrier, supporting the development and characterization of CNS-targeted biologics.

Explore Blood-Brain Barrier

Parkinson’s Disease Models

Developed through collaborations including The Michael J. Fox Foundation, Taconic's Parkinson's disease portfolio includes genetically engineered mouse and rat models targeting pathways associated with neurodegeneration, such as LRRK2, PINK1, PRKN, and SNCA.

Explore Parkinson's Disease Models

Neuropsychiatric Disorder Models

Taconic provides mouse and rat models to support investigation of neuropsychiatric disease mechanisms, including genetic pathways involved in neuronal function, behavior, and CNS signaling.

Explore Neuropsychiatric Models

Scientific Posters

Wednesday, November 18, 2026, 1:00 PM | Alzheimer's Disease: Neuroinflammation and Immune Actions: In Vivo Models II

Human APOE Isoforms Differentially Modulate Amyloid and Vascular Pathology in the Arte10 (APP:PS1) Alzheimer's Disease Mouse Model | Session Number: PSTR351

Sarah Sterlace, PhD, Taconic Biosciences

Tuesday, November 17, 2026, 1:00 PM + Tuesday, November 17, 2026, 5:00 PM | Genetic Techniques

Derivation and validation of germline-competent embryonic stem cells from immunodeficient NOG mice with targeted Tfrc humanization | Session Number: PSTR290

Moriah Jacobson, PhD, Taconic Biosciences

Sunday, November 15, 2026, 8:00 AM + Sunday, November 15, 2026, 12:00 PM | Blood Brain Barrier Function and Transport

Whole-Brain Quantification of BBB-Targeted Biologics Using a Humanized TfR1 (hTFRC) Mouse Model | Session Number: PSTR066

Alexis (Crockett) Vickers, PhD, Taconic Biosciences

Connect with Taconic's Neuroscience Experts

Meet with Taconic's scientific and commercial teams at SfN 2026 to discuss your research objectives, explore relevant neurobiology models, and identify solutions to support your next study.

Connect with one of our experts at SfN

Sarah Sterlace, PhD

Senior Director, Neurobiology and Rare Disease

Dr. Sarah Sterlace helps make innovative in vivo models and services accessible to neuroscience researchers around the world. With extensive experience translating complex research challenges into practical solutions, she partners with scientists across biotech, pharmaceutical, and academic organizations to advance preclinical discovery. Through these conversations, Sarah helps viewers explore emerging research approaches, model selection strategies, and opportunities to accelerate scientific progress.

Moriah Jacobson, PhD

Associate Director, Scientific Solutions

Dr. Moriah Jacobson joined Taconic Biosciences as a Field Applications Scientist in October 2020, and is now Associate Director, Scientific Solutions. She has deep expertise in the development, execution, and review of translational rodent studies. She obtained her Ph.D. in Integrative Neuroscience from Stony Brook University, where she discovered novel biomarkers for several models of chronic stress and chemotherapy-induced cognitive impairment and peripheral neuropathy. She then completed her postdoctoral research at Uniformed Services University where she studied novel rapid acting antidepressant drugs targeting kappa opioid receptors.

Caroline Mallick-Wood, PhD, MBA

Scientific Solutions Consultant

Alexis (Crockett) Vickers, PhD

Scientific Solutions Consultant

Jonathan Hancock, PhD

Scientific Solutions Consultant

Kelly Sharp

Client Relationship Manager

Webinar

Translational Mouse Models to Accelerate Neurodegenerative Disease Therapeutics

Watch this insightful webinar featuring Dr. Barry Bedell, as he explores the advanced characterization of mouse models engineered for preclinical testing of investigational treatments targeting neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis (ALS).

View the Webinar

Webinar

Taconic and Gubra Webinar: Quantitative 3D Whole-Brain Mapping of Sex-Specific Amyloid Pathology in the APP-PS1 (ARTE10) Mouse Model

Join Taconic and Gubra in this webinar to explore 3D whole-brain mapping of sex-specific amyloid pathology in the APP-PS1 (ARTE10) mouse model of Alzheimer’s disease.

View the Webinar

Insight

Breeding Complex Neurological Mouse Models | Challenges & Strategy Design

Learn how to successfully breed and manage complex neurological mouse models. Explore key challenges, colony management strategies, and best practices for improving cohort consistency and research outcomes.

Read the Insight

Insight

Why Neurological Disease Biology Requires Advanced Genetically Engineered Rodent Models

Learn why advanced genetically engineered rodent models are essential for neurological disease research, enabling accurate translation of complex genetic mechanisms.

Read the Insight

Scientific Poster

3D Whole-Brain Imaging in Collaboration with Gubra Reveals Sex-Dependent Amyloidosis in APP-PS1 (ARTE10) Mouse Model

Learn how Taconic and Gubra use 3D imaging to characterize parenchymal and vascular Aβ plaques in APP-PS1 (ARTE10) mice, informing preclinical Alzheimer’s research design.

Read Poster

Postcard

Alzheimer’s Disease Mouse Models for Drug Discovery & Therapeutic Research

Taconic offers state-of-the-art Alzheimer’s disease models that enhance our scientific understanding of disease progression and advance drug discovery efforts.

View the Postcard